Latest News
Urolution Medical secures FDA clearance for OpenFlo urinary catheter
9 October 2026 - Medical device company Urolution Medical Inc announced on Friday that it has received US Food and Drug Administration (FDA) 510(k) clearance for its OpenFlo Urinary Catheter, advancing the company toward clinical evaluation and comme...
Glaukos reports positive Phase 4 results for iDose TR with cataract surgery
9 October 2026 - Ophthalmic pharmaceutical and medical technology company Glaukos Corporation (NYSE:GKOS) on Friday announced positive topline results from its Phase 4 GLK-101-04 clinical trial evaluating iDose TR in combination with cataract surgery...
Natera secures FDA Breakthrough Device designation for multi-cancer early detection assay
9 October 2026 - Cell-free DNA and precision medicine company Natera Inc (NASDAQ:NTRA) announced on Friday that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its multi-cancer early detection (MCED) assay, su...
Medincell partner Teva secures FDA approval for monthly schizophrenia treatment
9 October 2026 - French biopharmaceutical company Medincell S.A. (Euronext Paris: MEDCL) announced on Friday that its partner Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) (TASE:TEVA), has received US Food and...
Alumis reports new Phase 3 data showing sustained skin clearance with envudeucitinib
9 October 2026 - US biopharmaceutical company Alumis Inc. (NASDAQ: ALMS) on Friday released new Phase 3 data from its ONWARD1, ONWARD2 and ONWARD3 studies of envudeucitinib in moderate-to-severe plaque psoriasis.Envudeucitinib delivered high-threshol...